Opal Bidco SAS and Clayton, Dubilier & Rice Fund XII have received tenders for 41.83% of their open offer targeting a 26% stake in Sanofi Consumer Healthcare India, with 25.05 lakh shares tendered so far.

Final share acceptance awaits validation and approvals.

This move advances their consolidation of a significant position in Sanofi Consumer Healthcare, potentially impacting shareholding control and future strategic decisions.